Skip to main content
Premium Trial:

Request an Annual Quote

Drug Maker Aryx to Use GenomeQuest's Sequence IP Search Service

NEW YORK (GenomeWeb News) — Aryx Therapeutics will use GenomeQuest’s sequence search service for use in intellectual property research related to its retrometabolic drug studies, GenomeQuest said today.
 
GenomeQuest’s software is used by researchers and IP lawyers to evaluate the patentability and competitive landscape for gene sequences.
 
Jeff Anderson, Aryx Therapeutics’ senior manager of IP, said his company looked to GenomeQuest to simplify the process of understanding the patent landscape that surrounds its IP interests in retrometabolic drug design.
  
Financial terms of the agreement were not released.

The Scan

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.

DNA Biobank Developed for French Kidney Donors, Recipients

The KiT-GENIE biobank described in the European Journal of Human Genetics contains DNA samples, genotyping profiles, immune patterns, and clinical features for thousands of kidney donors or transplant recipients in Nantes, France.

Cardiometabolic Disease May Have Distinct Associations With Microbial Metabolites in Blood, Gut

By analyzing gut microbes in combination with related metabolites in feces and blood, researchers in Nature Communications found distinct cardiometabolic disease relationships at each site.

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.